TCL Archive Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals May 25, 1984
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014